Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
CardioVascular and Interventional Radiology
Published in: CardioVascular and Interventional Radiology 4/2017

01-04-2017 | Clinical Investigation

Cutting Balloon Angioplasty (CBA) for the Treatment of Renal Artery Fibromuscular Dysplasia (FMD) in Six Patients: 5-Year Long-Term Results

Authors: Antonio Raffaele Cotroneo, Luigi Amoroso, Alberto Giammarino, Daniele Galasso, Francesco Taglialatela, Carmine Timpani, Daniela Gabrielli

Published in: CardioVascular and Interventional Radiology | Issue 4/2017

Login to get access

Abstract

Purpose

To evaluate long-term outcomes in terms of hypertension control, recurrent stenosis, and reinterventions from patients who underwent cutting balloon angioplasty (CBA) for symptomatic renal artery fibromuscular dysplasia (FMD).

Materials and Methods

From 2011, six consecutive renal artery FMD women underwent CBA for poorly controlled hypertension, despite antihypertensive therapy. Follow-up consisted of blood pressure monitoring and duplex ultrasonography at 1, 6, and 12 months and thereafter annually for 5 years.

Results

All treatments were technically successful. Recurrence of hypertension was found in two patients within 12 months, and reinterventions were performed using CBA.

Conclusion

Results show the efficacy of CBA for renal artery FMD.
Literature
1.
Trinquart L, Mounier-Vehier C, Sapoval M, Gagnon N, Plouin PF. Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension. 2010;56(3):525–32.CrossRefPubMed
2.
Weber BR, Dieter RS. Renal artery stenosis: epidemiology and treatment. Int J Nephrol Renovasc Dis. 2014;13(7):169–81.
3.
McCormack LJ, Poutasse EF, Meaney TF, Noto TJ Jr, Dustan HP. A pathologic-arteriographic correlation of renal arterial disease. Am Heart J. 1966;72:188–98.CrossRefPubMed
4.
Persu A, Touzé E, Mousseaux E, Barral X, Joffre F, Plouin PF. Diagnosis and management of fibromuscular dysplasia: an expert consensus. Eur J Clin Investig. 2012;42:338–47.CrossRef
5.
Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X. Fibromuscular dysplasia. Orphanet J Rare Disord. 2007;7(2):28.CrossRef
6.
Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary. J Am Coll Cardiol. 2006;47:1239–312.CrossRefPubMed
7.
Sandmann W, Dueppers P, Pourhassan S, Voiculescu A, Klee D, Balzer KM. Early and long-term results after reconstructive surgery in 42 children and two young adults with renovascular hypertension due to fibromuscular dysplasia and middle aortic syndrome. Eur J Vasc Endovasc Surg. 2014;47(5):509–16.CrossRefPubMed
8.
White CJ, Ramee SR, Collins TJ, Jenkins JS, Escobar A, Shaw D. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol. 1997;30:1445–50.CrossRefPubMed
9.
Rundback JH, Sacks D, Kent KG, Cooper C, Jones D, Murphy T, Rosenfield K, White C, Bettmann M, Cortell S, Puschett J, Clair DG, Cole P, For the American Heart Association Councils on Cardiovascular Radiology, High Blood Pressure Research, Kidney in Cardiovascular Disease, and Clinical Cardiology, and the Society of Interventional Radiology FDA Device Forum Committee. Guidelines for the reporting of renal artery revascularization in clinical trials. J Vasc Interv Radiol. 2003;14:S477–92.CrossRefPubMed
10.
Surowiec SM, Sivamurthy N, Rhodes JM, Lee DE, Waldman DL, Green RM, Davies MG. Percutaneous therapy for renal artery fibromuscular dysplasia. Ann Vasc Surg. 2003;17:650–5.CrossRefPubMed
11.
Lupattelli T, Nano G, Inglese L. Regarding cutting balloon angioplasty of renal fibromuscular dysplasia: a word of caution. J Vasc Surg. 2005;42(5):1038–9.CrossRefPubMed
12.
Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. The long term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia. J Vasc Surg. 2008;48:865–71.CrossRefPubMed
13.
Barrier P, Julien A, Guillaume C, Philippe O, Hervé R, Francis J. Technical and clinical results after percutaneous angioplasty in non medial fibromuscular dysplasia: outcome after endovascular management of unifocal renal artery stenosis in 30 patients. Cardiovasc Interv Radiol. 2010;33:270–7.CrossRef
14.
Mousa AY, Campbell JE, Stone PA, Broce M, Bates MC, AbuRahma AF. Short and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over ten-year period. J Vasc Surg. 2012;55:421–7.CrossRefPubMed
15.
Iwashima Y, Fukuda T, Yoshihara F, Kusunoki H, Kishida M, Hayashi S, Nakamura S, Kamide K, Horio T, Kawano Y. Incidence and risk factors for restenosis, and its impact on blood pressure control after percutaneous transluminal renal angioplasty in hypertensive patients with renal artery stenosis. J Hypertens. 2016;34(7):1407–15.CrossRefPubMed
16.
Meuse MA, Turba UC, Sabri SS, Park AW, Saad WE, Angle JF, Matsumoto AH. Treatment of renal artery fibromuscular dysplasia. Tech Vasc Interv Radiol. 2010;13(2):126–33.CrossRefPubMed
17.
Brountzos EN, Ptohis N, Triantafyllidi H, Panagiotou I, Spyridopoulos TN, Misiakos EP, Kelekis A. Renal artery rupture following cutting balloon angioplasty for fibromuscular dysplasia: a case report. Cases J. 2009;2:8881.CrossRefPubMedPubMedCentral
18.
Oguzkurt L, Tercan F, Gulcan O, Turkoz R. Rupture of the renal artery after cutting balloon angioplasty in a young woman with fibromuscular dysplasia. Cardiovasc Interv Radiol. 2005;28(3):360–3.CrossRef
19.
Caramella T, Lahoche A, Negaiwi Z, Lions C, Willoteaux S, Boivin V, Gaxotte V, Beregi JP. False aneurysm formation following cutting balloon angioplasty in the renal artery of a child. J Endovasc Ther. 2005;12(6):746–9.CrossRefPubMed
20.
Tanemoto M, Abe T, Chaki T, Satoh F, Ishibashi T, Ito S. Cutting balloon angioplasty of resistant renal artery stenosis caused by fibromuscular dysplasia. J Vasc Surg. 2005;41(5):898–901.CrossRefPubMed
21.
Haas NA, Ocker V, Knirsch W, Holder M, Lochbuehler H, Lewin MA, Uhlemann F. Successful management of a resistant renal artery stenosis in a child using a 4 mm cutting balloon catheter. Catheter Cardiovasc Interv. 2002;56:227–31.CrossRefPubMed
22.
Tanaka R, Higashi M, Naito H. Angioplasty for non-arteriosclerotic renal artery stenosis: the efficacy of cutting balloon angioplasty versus conventional angioplasty. Cardiovasc Interv Radiol. 2007;30(4):601–16.CrossRef
23.
Towbin RB, Pelchovitz DJ, Cahill AM, Baskin KM, Meyers KE, Kaplan BS, McClaren CA, Roebuck DJ. Cutting balloon angioplasty in children with resistant renal artery stenosis. J Vasc Interv Radiol. 2007;18(5):663–9.CrossRefPubMed
24.
Srinivasan A, Krishnamurthy G, Fontalvo-Herazo L, Nijs E, Keller MS, Meyers K, Kaplan B, Cahill AM. Angioplasty for renal artery stenosis in pediatric patients: an 11 year retrospective experience. J Vasc Interv Radiol. 2010;21(11):1672–80.CrossRefPubMed
25.
Metadata
Title
Cutting Balloon Angioplasty (CBA) for the Treatment of Renal Artery Fibromuscular Dysplasia (FMD) in Six Patients: 5-Year Long-Term Results
Authors
Antonio Raffaele Cotroneo
Luigi Amoroso
Alberto Giammarino
Daniele Galasso
Francesco Taglialatela
Carmine Timpani
Daniela Gabrielli
Publication date
01-04-2017
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 4/2017
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-016-1536-6

Other articles of this Issue 4/2017

CardioVascular and Interventional Radiology 4/2017 Go to the issue

Review

Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease

Technical Note

Using a Motion Sensor-Equipped Smartphone to Facilitate CT-Guided Puncture

Letter to the Editor

Trerotola Device Fragmentation

Clinical Investigation

Prostatic Artery Embolization as an Alternative to Indwelling Bladder Catheterization to Manage Benign Prostatic Hyperplasia in Poor Surgical Candidates

Case Report

Endovascular Mechanical Thromboaspiration of Right Hepatic Arterial Thrombosis After Liver Transplantation

Clinical Investigation

Radiofrequency Ablation Combined with Hepatic Arterial Chemoembolization Using Degradable Starch Microsphere Mixed with Mitomycin C for the Treatment of Liver Metastasis from Colorectal Cancer: A Prospective Multicenter Study